Login
Home / AYTU : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aytu BioPharma, Inc.

$2 -$0.77 (-27.80%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$1.99
Day Range
$1.95$2.09
Year Range
$1.65$3.07
Market Cap
21.47M
AVG Volume
33.73K
Trailing/Forward PE
-0.47/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-09-22
Primary Exchange
NASDAQUS
Revenue (USD)
05M10M15M20M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Net Income (USD)
-20M-10M010M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Operating Income (USD)
-10M-5M05M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
EBITDA (USD)
-20M-10M010M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Cash Flows (USD)
-10M-5M05M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
EPS (USD)
-3-2-10124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Expenses (USD)
05M10M15MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Cash & Debt (USD)
010M20M30M40MCashLong Term DebtShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Debt ratios
-3-2-101224 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Margins
0%20%40%60%80%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Return on Capital
-150%-100%-50%0%50%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Shares Outstanding
05M10M15M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Book Value Per Share (USD)
024624 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Total Assets (USD)
050M100M150M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Employee Count
0501001502002016201720182019202020212022202320242025
PE Ratio
678910med 8.27May 25Jun 25Jun 25Jul 25Aug 25Aug 25Sep 25
Free Cash Flow Yield
-60%-40%-20%0%20%med -5.99%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
00.10.20.30.40.5med 0.21Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
1.522.533.5med 2.82Jun 24Aug 24Dec 24Feb 25May 25Jul 25Sep 25
Price/Operating Cashflow
051015med 3.74Jan 24Apr 24Jun 24Sep 24Apr 25Jun 26Sep 26
Price to Book
00.511.52med 0.61Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Aytu BioPharma, Inc.
AYTU
Stockpicker

Video analysis: AYTU

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AYTU

AWM Investment Company Inc. Invests $1.33 Million in Aytu BioPharma Inc. $AYTU

defenseworld.net · 26 Aug 2026

AWM Investment Company Inc. Invests $1.33 Million in Aytu BioPharma Inc. $AYTU

AWM Investment Company Inc. bought a new stake in Aytu BioPharma Inc. (NASDAQ: AYTU) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 619,574 shares of the company's stock, valued at approximately $1,332,000. AWM Investment Company Inc. owned
New Strong Sell Stocks for July 20th

zacks.com · 20 Jul 2026

New Strong Sell Stocks for July 20th

ACR, AEM and AYTU have been added to the Zacks Rank #5 (Strong Sell) List on July 20, 2026.
New Strong Sell Stocks for July 16th

zacks.com · 16 Jul 2026

New Strong Sell Stocks for July 16th

AYTU, CAMP and CRC have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2026.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.